We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Single Domain Antibodies: From Conformational Sensors to Bispecific Antibodies for Immunotherapy

Video   Dec 23, 2016

 

Single domain antibodies (AKA nanobodies), the variable domains of some camelid antibodies, have interesting properties, including high production yields and stability but also the ability to bind unusual epitopes such as cleft and cavities. We are using them as innovative tools such as biosensors able to capture the conformation states of some membrane receptors such as EGFR or metabotropic glutamate receptors (mGluRs) on living cells. Combined with time-resolved FRET assays, they can reveal the fine mechanisms of receptor activation at the cell surface.Single domain antibodies also represent efficient building blocks to create bispecific molecules that we are using to immunomolulate effectors cells in the tumor microenvironment. An example will be given with the activation of effector cells such as NK cells in the context of tumor cells expressing low amount of tumor antigens, outperforming the classical ADCC mechanisms.

 
 
 
 

Recommended Videos

How Fungus-Farming Ants Might Help us Develop New Antibiotics

Video

Scientists are trying to develop new antibiotics for humans from the bacteria leafcutter ants are carrying on their bodies to protect the fungus they farm from other microbes.

WATCH NOW

Superbugs: The Fight for Our Lives

Video

Sheldon Paquin explores how society is responding to the enormous challenge of antibiotic resistance.

WATCH NOW

Is the Future of Medicine Lurking in Iceland's Icy Waters?

Video

Antibiotics are losing their effectiveness, threatening to make common infections deadly. Is the future of medicine lurking in Iceland's icy waters?

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE